C116H97Cl5N38O11S5 — CID 161366086
N-[5-(8-chloroquinolin-6-yl)-3-cyano-6-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-cyclopentylethanesulfonamide;N-[5-(8-chloroquinolin-6-yl)-3-cyano-6-(1-methylpyrazol-3-yl)pyrazin-2-yl]methanesulfonamide;N-[5-(8-chloroquinolin-6-yl)-3-cyano-6-(1-methylpyrazol-3-yl)pyrazin-2-yl]-1-(1-methylpyrrol-3-yl)methanesulfonamide;N-[5-(8-chloroquinolin-6-yl)-3-cyano-6-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-(oxan-4-yl)ethanesulfonamide;N-[5-(8-chloroquinolin-6-yl)-3-cyano-6-(1-methylpyrazol-3-yl)pyrazin-2-yl]-1-pyrimidin-5-ylmethanesulfonamide (PubChem CID 161366086) has the molecular formula C116H97Cl5N38O11S5 and a molecular weight of 2536.91 g/mol. Its IUPAC name is N-[5-(8-chloroquinolin-6-yl)-3-cyano-6-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-cyclopentylethanesulfonamide;N-[5-(8-chloroquinolin-6-yl)-3-cyano-6-(1-methylpyrazol-3-yl)pyrazin-2-yl]methanesulfonamide;N-[5-(8-chloroquinolin-6-yl)-3-cyano-6-(1-methylpyrazol-3-yl)pyrazin-2-yl]-1-(1-methylpyrrol-3-yl)methanesulfonamide;N-[5-(8-chloroquinolin-6-yl)-3-cyano-6-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-(oxan-4-yl)ethanesulfonamide;N-[5-(8-chloroquinolin-6-yl)-3-cyano-6-(1-methylpyrazol-3-yl)pyrazin-2-yl]-1-pyrimidin-5-ylmethanesulfonamide.
| Compound Name | N-[5-(8-chloroquinolin-6-yl)-3-cyano-6-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-cyclopentylethanesulfonamide;N-[5-(8-chloroquinolin-6-yl)-3-cyano-6-(1-methylpyrazol-3-yl)pyrazin-2-yl]methanesulfonamide;N-[5-(8-chloroquinolin-6-yl)-3-cyano-6-(1-methylpyrazol-3-yl)pyrazin-2-yl]-1-(1-methylpyrrol-3-yl)methanesulfonamide;N-[5-(8-chloroquinolin-6-yl)-3-cyano-6-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-(oxan-4-yl)ethanesulfonamide;N-[5-(8-chloroquinolin-6-yl)-3-cyano-6-(1-methylpyrazol-3-yl)pyrazin-2-yl]-1-pyrimidin-5-ylmethanesulfonamide |
|---|---|
| PubChem CID | 161366086 |
| Molecular Formula | C116H97Cl5N38O11S5 |
| Molecular Weight | 2536.91 g/mol |
| Exact Mass | 2532.52 |
| IUPAC Name | N-[5-(8-chloroquinolin-6-yl)-3-cyano-6-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-cyclopentylethanesulfonamide;N-[5-(8-chloroquinolin-6-yl)-3-cyano-6-(1-methylpyrazol-3-yl)pyrazin-2-yl]methanesulfonamide;N-[5-(8-chloroquinolin-6-yl)-3-cyano-6-(1-methylpyrazol-3-yl)pyrazin-2-yl]-1-(1-methylpyrrol-3-yl)methanesulfonamide;N-[5-(8-chloroquinolin-6-yl)-3-cyano-6-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-(oxan-4-yl)ethanesulfonamide;N-[5-(8-chloroquinolin-6-yl)-3-cyano-6-(1-methylpyrazol-3-yl)pyrazin-2-yl]-1-pyrimidin-5-ylmethanesulfonamide |
| SMILES | Cn1ccc(-c2nc(NS(=O)(=O)CCC3CCCC3)c(C#N)nc2-c2cc(Cl)c3ncccc3c2)n1.Cn1ccc(-c2nc(NS(=O)(=O)CCC3CCOCC3)c(C#N)nc2-c2cc(Cl)c3ncccc3c2)n1.Cn1ccc(-c2nc(NS(=O)(=O)Cc3cncnc3)c(C#N)nc2-c2cc(Cl)c3ncccc3c2)n1.Cn1ccc(-c2nc(NS(C)(=O)=O)c(C#N)nc2-c2cc(Cl)c3ncccc3c2)n1.Cn1ccc(CS(=O)(=O)Nc2nc(-c3ccn(C)n3)c(-c3cc(Cl)c4ncccc4c3)nc2C#N)c1 |
| InChI | InChI=1S/C25H24ClN7O3S.C25H24ClN7O2S.C24H19ClN8O2S.C23H16ClN9O2S.C19H14ClN7O2S/c1-33-9-4-20(31-33)24-23(18-13-17-3-2-8-28-22(17)19(26)14-18)29-21(15-27)25(30-24)32-37(34,35)12-7-16-5-10-36-11-6-16;1-33-11-8-20(31-33)24-23(18-13-17-7-4-10-28-22(17)19(26)14-18)29-21(15-27)25(30-24)32-36(34,35)12-9-16-5-2-3-6-16;1-32-8-5-15(13-32)14-36(34,35)31-24-20(12-26)28-22(23(29-24)19-6-9-33(2)30-19)17-10-16-4-3-7-27-21(16)18(25)11-17;1-33-6-4-18(31-33)22-21(16-7-15-3-2-5-28-20(15)17(24)8-16)29-19(9-25)23(30-22)32-36(34,35)12-14-10-26-13-27-11-14;1-27-7-5-14(25-27)18-17(23-15(10-21)19(24-18)26-30(2,28)29)12-8-11-4-3-6-22-16(11)13(20)9-12/h2-4,8-9,13-14,16H,5-7,10-12H2,1H3,(H,30,32);4,7-8,10-11,13-14,16H,2-3,5-6,9,12H2,1H3,(H,30,32);3-11,13H,14H2,1-2H3,(H,29,31);2-8,10-11,13H,12H2,1H3,(H,30,32);3-9H,1-2H3,(H,24,26) |
| InChIKey | VPVDYYCAPFPCQI-UHFFFAOYSA-N |
| XLogP | 19.35 |
| TPSA | 672.19 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 44 |
| Rotatable Bonds | 30 |
| Heavy Atoms | 175 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2536.91 |
| LogP ≤ 5 | 19.35 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 44 |